Tissue Gene Expression of Renin-Angiotensin System in Human Type 2 Diabetic Nephropathy

Konoshita, Tadashi; Wakahara, Shigeyuki; Mizuno, Shinichi; Motomura, Makoto; Aoyama, Chikako; Makino, Yasukazu; Kawai, Yasuyuki; Kato, Norihiro; Koni, Ichiro; Miyamori, Isamu; Mabuchi, Hiroshi
April 2006
Diabetes Care;Apr2006, Vol. 29 Issue 4, p848
Academic Journal
OBJECTIVE -- Recent studies have proved that blockade of the renin-angiotensin system (RAS) retards the progression of diabetic nephropathy, whereas hyporeninemia is known as a typical state in diabetic subjects. The purpose of this study is to determine whether expression levels of RAS differ between nondiabetic and diabetic renal tissues with accurate quantitative method. RESEARCH DESIGN AND METHODS -- Subjects were 66 nondiabetic and 8 diabetic patients with biopsy-proven renal diseases. The eight diabetic subjects suffered from type 2 diabetes with overt proteinuria. Renal histology revealed typical diffuse or nodular lesions with linear IgG deposit on immunofluorescent staining and thickened basement membrane on electronic microscopy. Total RNA from a small part of the renal cortical biopsy specimens was reverse-transcribed, and the resultant cDNA was amplified for new major components of RAS (i.e., renin, renin receptor, angiotensinogen, ACE, ACE2, angiotensin II type 1 receptor, and angiotensin 11 type 2 receptor) and measured. RESULTS -- Among these components, a significant upregulation was observed in the ACE gene in diabetic renal tissue. CONCLUSIONS -- The results suggest that renal tissue RAS might be activated in the respect that ACE gene expression is upregulated in spite of a tendency to low renin expression in type 2 diabetic nephropathy.


Related Articles

  • Renin and angiotensinogen gene expression in experimental diabetes mellitus. Correa-Rotter, Ricardo; Hostetter, Thomas H.; Rosenberg, Mark E. // Kidney International;Apr1992, Vol. 41 Issue 4, p796 

    The renin-angiotensin system may play a role in the initiation and progression of diabetic kidney disease. In this study, the local intrarenal renin-angiotensin system was examined in streptozotocin-treated rats maintained moderately hyperglycemic by daily low-dose insulin injection. Four weeks...

  • Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Mezzano, Sergio; Droguett, Alejandra; Burgos, M. Eugenia; Ardiles, Leopoldo G.; Flores, Claudio A.; Aros, Claudio A.; Carlos, Italo; Vío, Carlos P.; Ruiz-Ortega, Marta; Egido, Jesús // Kidney International Supplement;Oct2003, Issue 86, p64 

    Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Background. The molecular mechanisms of renal injury in diabetic nephropathy (DN) are not completely understood, although inflammatory cells play a key role. The renin-angiotensin system (RAS) is...

  • The connection between GRKs and various signaling pathways involved in diabetic nephropathy. Wang, Feng-Ling; Tang, Li-Qin; Wei, Wei // Molecular Biology Reports;Jul2012, Vol. 39 Issue 7, p7717 

    Diabetic nephropathy (DN) is a known microvascular complication in patients with diabetes mellitus. DN has become one of the main causes of death in diabetic patients. The occurrence and development of DN results from the comprehensive action of multi-factors, though the exact mechanism is not...

  • Comprehensive Diabetes Care: The Whole Enchilada. Kuritzky, Louis // Internal Medicine Alert;3/29/2008, Vol. 30 Issue 6, p48 

    The article focuses on a study on diabetics which demonstrated that although glucocentric focus in diabetes produces microvascular benefits, dealing with the factors like blood pressure (BP), lipids, the renin-angiotensin system, and platelets benefits the patient.

  • Diabetes clinical studies.  // Nephrology Dialysis Transplantation;May2012 Supplement 2, Vol. 27 Issue suppl_2, pii55 

    No abstract available.

  • Renal vascular responsiveness to angiotensin II at an early stage of diabetes: interaction between intrarenal noradrenergic and renin-angiotensin systems. García, V. M. C.; Monasterolo, L. A.; Elías, M. M. // Acta Diabetologica;Sep2003, Vol. 40 Issue 3, p130 

    The renin-angiotensin system (RAS) has been implicated in haemodynamic maladaptations of diabetic kidney. Its effects may be modulated by endogenous substances like noradrenaline. Our aim was to study renal vascular response to angiotensin II and the interaction between intrarenal RAS and...

  • Alterations of intrarenal renin-angiotensin and nitric oxide systems in streptozotocin-induced diabetic rats. Ki Chul Choi; Nam Ho Kim; Mi Ra An; Dae Gill Kang; Soo Wan Kim; Jong-un Lee // Kidney International Supplement;Sep1997, Issue 60, pS-23 

    Investigates the changes in the renin-angiotensin and nitric oxide (NO) systems in the early phase of diabetes. Determination of the protein levels of different isoforms of NO synthases by Northern and Western blot analyses; Injection of male Sprague-Dawley rats with streptozotocin; Measurement...

  • Renoprotection with vitamin D: Specific for diabetic nephropathy? Klaus, G. // Kidney International;Jan2008, Vol. 73 Issue 2, p141 

    Zhang and co-workers report on the renoprotective role of the vitamin D receptor (VDR) in diabetic nephropathy using the method of streptozotocin-induced hyperglycemia in wild-type and VDR–/– mice. Also, experiments with cultured mesangial cells and podocytes confirm the effect of...

  • Dyslipidemia and the progression of renal disease in chronic renal failure patients. Cases, Aleix; Coll, Elisabet // Kidney International Supplement;Dec2005, Issue 99, pS87 

    Dyslipidemia is a common complication of progressive kidney disease and contributes to the high cardiovascular morbidity and mortality of chronic kidney disease (CKD) patients. Recent evidence also suggests a role for dyslipidemia in the development and progression of renal disease. Experimental...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics